Propagenix For Profit
.jpg)
AxoGen is a biotech company developing treatment options for the reconstruction and repair of peripheral nerve injuries.
Technology:
Other
Industry:
Regenerative medicine
Headquarters:
United States
Investors Number:
4
Total Funding:
$95M
Estimated Revenue:
$100M to $500M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership